| 000 | 01072 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514210002.0 | ||
| 264 | 0 | _c20050308 | |
| 008 | 200503s 0 0 ger d | ||
| 022 | _a0020-9554 | ||
| 024 | 7 |
_a10.1007/s00108-004-1297-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMüller-Ladner, U | |
| 245 | 0 | 0 |
_a[Are "biologics" in the treatment of rheumatoid arthritis really cost effective?]. _h[electronic resource] |
| 260 |
_bDer Internist _cDec 2004 |
||
| 300 |
_a1402-6 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xeconomics |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xeconomics |
| 650 | 0 | 4 |
_aBiological Products _xeconomics |
| 650 | 0 | 4 |
_aCost-Benefit Analysis _xmethods |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aQuality-Adjusted Life Years |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tDer Internist _gvol. 45 _gno. 12 _gp. 1402-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00108-004-1297-1 _zAvailable from publisher's website |
| 999 |
_c15205439 _d15205439 |
||